Compound CMX410 blocks key enzyme in tuberculosis, offering hope for drug-resistant infections

Scientists have developed a new compound that could offer a breakthrough in the global fight against tuberculosis, history’s deadliest infectious disease.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup